Fresenius (Germany) Today
| FRE Stock | 33.36 0.05 0.15% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Fresenius is selling for under 33.36 as of the 26th of November 2024; that is 0.15% up since the beginning of the trading day. The stock's last reported lowest price was 33.2. Fresenius has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Fresenius SE Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Moving against Fresenius Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fresenius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fresenius' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fresenius or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres CEO | Michael Sen |
| Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
Fresenius SE Co (FRE) is traded on XETRA Stock Exchange in Germany and employs 319,691 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fresenius's market, we take the total number of its shares issued and multiply it by Fresenius's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fresenius SE operates under Healthcare sector and is part of Medical Care Facilities industry. The entity has 563.24 M outstanding shares.
Fresenius SE Co has accumulated about 931 M in cash with 5.08 B of positive cash flow from operations.
Check Fresenius Probability Of Bankruptcy
Ownership AllocationFresenius holds a total of 563.24 Million outstanding shares. Fresenius SE Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fresenius Ownership Details
Fresenius SE Risk Profiles
Although Fresenius' alpha and beta are two of the key measurements used to evaluate Fresenius' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.8158 | |||
| Semi Deviation | 1.05 | |||
| Standard Deviation | 1.11 | |||
| Variance | 1.23 |
Fresenius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fresenius without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Fresenius Corporate Management
Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Francesco Meo | Member SE | Profile | |
| Helen Giza | Member SE | Profile | |
| Ernst Wastler | Member SE | Profile | |
| Sebastian Biedenkopf | HR, Officer | Profile | |
| Matthias Link | Sr Communications | Profile |
Additional Tools for Fresenius Stock Analysis
When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.